China Traditional Chinese Medicine Market is expected to grow with the CAGR of 6.6% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below:
China traditional Chinese medicine market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in China traditional Chinese medicine market are introducing strong range of medicines provider along with launching new medicines and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.
China Traditional Chinese Medicine Holdings Co. Limited is the dominating player in China traditional Chinese medicine market. The other key players existing in the market includes China SXT Pharmaceuticals, Inc., Merro Pharmaceutical Co.,Ltd, PuraPharm International (H.K.) Ltd., Zhangzhou Pien Tze Huang Pharmaceutical Co.,Ltd, Tasly.Phar. International Co.,Ltd., Zhengzhou Ruilong Pharmaceutical Co.,Ltd., Yunnan Baiyao, Impression Jumpcan, Guangzhou Pharmaceutical Holdings Limited, Kangmei Pharmaceutical Co., Ltd., Beijing Tong Ren Tang Chinese Medicine Co. Ltd., Xiamen Traditional Chinese Medicine Co., Ltd., aroma, KPC Pharmaceuticals, Inc, among others.
China Traditional Chinese Medicine Holdings Co. Limited headquarters is in Guangdong, China. The company is focused on the essence of traditional Chinese medicine which is in existence from more than 400 years. The company has multiple business segments including finished drugs, concentrated TCM granules, TCM decoction pieces, TCM healthcare complex, local TCM integrated operation in this finished drugs is the market focused segment. The company has three product categories which are drug display, slices and granules in which drug display is the market focused category.
The company has presence across Asia. The company has various subsidiaries which are Guangdong Yifang Pharmaceutical Co., Ltd. (China), Sinopharm Group Feng Liao Xing Traditional Chinese Medicine Health Industry Company Limited (China), Longxi Yifang Pharmaceutical Co., Ltd. (China), Beijing Huatai Chinese Medicine New Technology Development Limited Liability Company (China), Jiangyin Tianjiang Chinese Medical Clinics Ltd. (China) among others.
Guangzhou Pharmaceutical Holdings Limited
Guangzhou Pharmaceutical Holdings Limited headquartered in Guangzhou, China. The company is focused on the research and development of Chinese patent medicine, Chinese herbal medicine, chemical pharmaceutical raw materials and preparations, biological medicine and healthcare products and to pharmaceutical logistics and distribution and healthcare service. The company has wide product portfolio including refreshing ciningji drink to beat the heat, Huatuo Zaizao Pills, Angongniuhuang Pills, Triamcinolone Acetonide Acetate and Miconazole Nitrate and Neomycin Sulfate Cream, Xia Sang Ju Ke Li, WonLucky Herbal Tea, “701” Dieda Zhentong Gao (Adhesive Plaster for Bruise and Analgesic), Ban Lan Gen Granules, Xiaochaihu Keli, Sildenafil Citrate Tablet, Shedan Chuanbei Pipa Gao in which Ban Lan Gen Granules, Xia Sang Ju Ke Li, Angongniuhuang Pills, Huatuo Zaizao Pills, WonLucky Herbal Tea, Xiaochaihu Keli, Shedan Chuanbei Pipa Gao are the market focused products.
The company has presence in Asia. The company has various subsidiaries such as Guangzhou Chenliji Pharmaceutical Factory (China), Guangzhou Jingxiutang Pharmaceutical Co., Ltd. (China), Guangzhou Caizhilin Pharmaceutical Co., Ltd. (China), Guangzhou Wanglaoji Pharmaceutical Co., Ltd. (China), Guangzhou Xingqun Pharmaceutical Co., Ltd. (China), among others.
Yunnan Baiyao was founded in 1971. The company is engaged in the development, production and marketing of chemical raw materials, chemical preparations, Chinese patent medicines, Chinese traditional medicines, biological products, health food, cosmetics and beverages and medical devices. The company is engaged in providing wide range of products such as 100 boxes yunnan baiyao capsules, 50 boxes yunnan baiyao capsules, 80 boxes yunnan baiyao capsules, yunnan baiyao aerosol/spray (two bottles in one box) to treat sports injuries, sprains, bruises, fractures, 6 bottles of yunnan baiyao powder for bleeding or hematoma (4g/bottle) which all are market focused products.
The company is present in Asia, Europe, America. The company has various subsidiaries such as Yunnan Baiyao Qingyitang Industrial Co., Ltd. (China), Yunnan Baiyao Group Wenshan Qihua Co., Ltd (China), Yunnan Institute of Materia Medica (China), Yunnan Baiyao Group Lijiang Pharmaceutical Co, Ltd. (China), Yunnan Baiyao Group Yunfeng Import & Export Trading Co., Ltd (China), among others.
China Traditional Chinese Medicine Market – Industry Trends and Forecast to 2027